Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: A sociocultural perspective

Emerging Infectious Diseases

Volumn 8, Issue 12, 2002, Pages 1460-1467

  Harbarth, Stephan ^a   Albrich, Werner ^b   Brun Buisson, Christian ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; CHILD CARE; CULTURAL FACTOR; FRANCE; GERMANY; HUMAN; NONHUMAN; OUTPATIENT; PRESCRIPTION; PREVALENCE; RESPIRATORY TRACT INFECTION; REVIEW; SOCIAL ASPECT; STREPTOCOCCUS PNEUMONIAE;

EID: 0036913870     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0812.010533     Document Type: Review

References (81)

1. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32(Suppl 2):S81-93.
2. Pradier C, Dunais B, Carsenti-Etesse H, Dellamonica P. Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis 1997;16:644-7.
3. Schmitz FJ, Verhoef J, Fluit AC. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SEN-TRY surveillance programme. J Antimicrob Chemother 1999;43:783-92.
4. Anell A, Willis M. International comparison of health care systems using resource profiles. Bull World Health Organ 2000;78:770-8.
5. Wessling A, Boethius G. Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology. Eur J Clin Pharmacol 1990;39:207-10.
6. Jacobs MR, Felmingham D, Appelbaum PC. Penicillin and macrolide resistance in 2,675 isolates of Streptococcus pneumoniae from 15 countries on five continents [Abstract]. ICAAC. San Francisco: American Society for Microbiology; 1999. p. 1044.
7. Reinert RR, Simic S, Al-Lahham A, Reinert S, Lemperle M, Lutticken R. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: Results of a national surveillance study. J Clin Microbiol 2001;39:1187-9.
8. Thierry J, Perrier-Gros-Claude JD, Clavier B, Dumas M, Aubert G, Barbe G, et al. [Pneumococcus observatory data in the Rhone-Alps region. Results from 1996]. Pathol Biol (Paris) 1999;47:1060-4.
9. Sahm DF, Jones ME, Hickey ML, Diakun DR, Mani SV, Thomsberry C. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J Antimicrob Chemother 2000;45:457-66.
10. Chomarat M. [Pneumococcal antibiotic resistance in 1999. Results from 19 registries for 1999]. Presse Med 2001;1:5-6.
11. Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, et al. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 2002;49:61-8.
12. Bouvenot G. French National Institute for observation of prescriptions and consumption of medicines. Prescription and consumption of antibiotics in ambulatory care. Bull Acad Natl Med 1999;183:601-13.
13. Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: The nonpharmacologic basis of therapeutics. Ann Intern Med 2000;133:128-35.
14. Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: Do international comparisons help? Lancet Infect Dis 2001;1:251-61.
15. Samore MH, Magill MK, Alder SC, Severina E, Morrison-De Boer L, Lyon JL, et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: Association with cephalosporin use and intrafamilial transmission. Pediatrics 2001;108:856-65.
16. Chiu SS, Ho PL, Chow FK, Yuen KY, Lau YL. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob Agents Chemother 2001;45:2765-70.
17. Klugman KP. Antibiotic selection of multiply resistant pneumococci. Clin Infect Dis 2001;33:489-91.
18. McManus P, Hammond ML, Whicker SD, Primrose JG, Mant A, Fairall SR. Antibiotic use in the Australian community, 1990-1995. Med J Aust 1997;167:124-7.
19. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851-3.
20. Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: A European survey. Eur Respir J 1996;9:1590-5.
21. Woodhead M, Gialdroni Grassi G, Huchon GJ, Leophonte P, Manresa F, Schaberg T. Use of investigations in lower respiratory tract infection in the community: A European survey. Eur Respir J 1996;9:1596-600.
22. Guillemot D, Maison P, Carbon C, Balkau B, Vauzelle-Kervroedan F, Sermet C, et al. Trends in antimicrobial drug use in the community -France, 1981-1992. J Infect Dis 1998;177:492-7.
23. Raherison C, Peray P, Poirier R, Romand P, Grignet JP, Arsac P, et al. Management of lower respiratory tract infections by French general practitioners: The AIR 11 study. Eur Respir J 2002;19:314-9.
24. Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroedan F, et al. Low dosage and long treatment duration of beta-lac-tam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998;279:365-70.
25. Guillemot D, Carbon C, Vauzelle-Kervroedan F, Balkau B, Maison P, Bouvenot G, et al. Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol 1998;51:61-8.
26. Ball P, Baquero F, Cars O, File T, Garau J, Klugman K, et al. Antibiotic therapy of community respiratory tract infections: Strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002;49:31-40.
27. Schrag SJ, Pena C, Fernandez J, Sanchez J, Gomez V, Perez E, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: A randomized trial. JAMA 2001;286:49-56.
28. de Melker RA, Touw-Otten FW, Kuyvenhoven MM. Transcultural differences in illness behaviour and clinical outcome: An underestimated aspect of general practice? Fam Pract 1997;14:472-7.
29. Pradier C, Rotily M, Cavailler P, Haas H, Pesce A, Dellamonica P, et al. Factors related to the prescription of antibiotics for young children with viral pharyngitis by general practitioners and pediatricians in southeastern France. Eur J Clin Microbiol Infect Dis 1999;18:510-4.
30. Melchart D, Walther E, Linde K, Brandmaier R, Lersch C. Echinacea root extracts for the prevention of upper respiratory tract infections: A double-blind, placebo-controlled randomized trial. Arch Fam Med 1998;7:541-5.
31. Wahlstrom R, Lagerlov P, Lundborg CS, Veninga CCM, Hummers-Pradier E, Dahlgren LO, et al. Variations in general practitioners' views of asthma management in four European countries. Soc Sci Med 2001;53:507-18.
32. Homoeopathic Medicine Research Group. Homoeopathic Medicine in Europe. Vol. DGXII. Brussels: Commission des Communautes Europeennes; 1996.
33. Buhring P. Ganzheitliche therapie gewünscht. Deutsches Ärzteblatt 2001;98:1307.
34. Ernst E. Prevalence of use of complementary/alternative medicine: A systematic review. Bull World Health Organ 2000;78:252-7.
35. Payer L. Medicine and Culture: Varieties of Treatment in the United States, England, West Germany, and France. New York: Henry Holt and Company; 1988.
36. Branthwaite A, Pechere JC. Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J Int Med Res 1996;24:229-38.
37. De Saint-Hardouin G, Goldgewicht M, Kemeny CT, Rufat P, Perronne C. Evaluation de la pression des parents sur les medecins pour la prescription des antibiotiques dans les infections ORL de l'enfant en ville. Med Mal Infect 1997;27:372-8.
38. Sorum PC, Shim J, Chasseigne G, Mullet E, Sastre MT, Stewart T, et al. Do parents and physicians differ in making decisions about acute otitis media? J Fam Pract 2002;51:51-7.
39. Pichichero ME. Understanding antibiotic overuse for respiratory tract infections in children. Pediatrics 1999;104:1384-8.
40. Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: Blinded, randomised controlled trial of patient information leaflet. BMJ 2002;324:1-6.
41. Rovers MM, Zielhuis GA, Ingels K, van der Wilt GJ. Day-care and otitis media in young children: A critical overview. Eur J Pediatr 1999;158:1-6.
42. Cooper CJ. Ready to Learn - The French System of Early Education and Care Offers Lessons for the United States. New York: French-American Foundation; 1999.
43. Tageseinrichtungen Für Kinder. Wiesbaden, Germany: Statistisches Bundesamt; 2000.
44. Daly KA, Giebink GS. Clinical epidemiology of otitis media. Pediatr Infect Dis J 2000;19(5 Suppl):S31-6.
45. Aubry-Damon H, Carlet J, Courvalin P, Desenclos JC, Drucker J, Guillemot D, et al. Bacterial resistance to antibiotics in France: A public health priority. Eurosurveillance 2000;5:135-8.
46. Khlat M, Sermet C, Le Pape A. Women's health in relation with their family and work roles: France in the early 1990s. Soc Sci Med 2000;50:1807-25.
47. Fean A. France shows way with childcare. Times 1997 June 13; p. 7.
48. Hardy AM, Fowler MG. Child care arrangements and repeated ear infections in young children, Am J Public Health 1993;83:1321-5.
49. Leino T, Auranen K, Jokinen J, Leinonen M, Tervonen P, Takala AK. Pneumococcal carriage in children during their first two years: Important role of family exposure. Pediatr Infect Dis J 2001;20:1022-7.
50. Giebink GS. The prevention of pneumococcal disease in children. N Engl J Med 2001;345:1177-83.
51. Freeman V, van't Hof M, Haschke F. Patterns of milk and food intake in infants from birth to age 36 months: The Euro-growth study. J Pediatr Gastroenterol Nutr 2000;31(Suppl 1):S76-85.
52. Crost M, Kaminski M. Breast feeding at maternity hospitals in France in 1995. National perinatal survey]. Arch Pediatr 1998;5:1316-26.
53. Le Pen C. Pharmaceutical economy and the economic assessment of drugs in France. Soc Sci Med 1997;45:635-43.
54. Danzon PM, Chao LW. Cross-national price differences for pharmaceuticals: How large, and why? J Health Econ 2000;19:159-95.
55. Bergan T. Antibiotic usage in Nordic countries. Int J Antimicrob Agents 2001;18:279-82.
56. Organisation for Economic Co-operation and Development. OECD Health Data. Paris: The Organisation; 2000.
57. Giuliani G, Selke G, Garattini L. The German experience in reference pricing. Health Policy 1998;44:73-85.
58. Dickson M. The pricing of pharmaceuticals: An international comparison. Clin Ther 1992;14:604-10.
59. Garattini L, Tediosi F. A comparative analysis of generics markets in five European countries. Health Policy 2000;51:149-62.
60. Huttin C. A critical review of the remuneration systems for pharmacists. Health Policy 1996;36:53-68.
61. Choutet P. Impact of opposable medical references prescription guidelines for antibiotic prescriptions in ambulatory medicine. Therapie 2001;56:139-42.
62. Reichmann P, Varon E, Gunther E, Reinert RR, Luttiken R, Marton A, et al. Penicillin-resistant Streptococcus pneumoniae in Germany: Genetic relationship to clones from other European countries. J Med Microbiol 1995;43:377-85.
63. Geslin P, Fremaux A, Sissia G, Spicq C. [Streptococcus pneumoniae: Serotypes, invasive and antibiotic resistant strains. Current situation in France]. Presse Med 1998;27(Suppl 1):21-7.
64. Kries R, Siedler A, Schmitt HJ, Reinert RR. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 2000;31:482-7.
65. Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001;357:950-2.
66. Van Veldhuisen DJ, Charlesworth A, Crijns HJ, Lie KI, Hampton JR. Differences in drug treatment of chronic heart failure between European countries. Eur Heart J 1999;20:666-72.
67. Durieux P, Gaillac B, Giraudeau B, Doumenc M, Ravaud P. Despite financial penalties, French physicians' knowledge of regulatory practice guidelines is poor. Arch Fam Med 2000;9:414-8.
68. Metlay JP, Shea JA, Crossette LB, Asch DA. Tensions in antibiotic prescribing - Pitting social concerns against the interests of individual patients. J Gen Intern Med 2002;17:87-94.
69. Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: Qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 1998;317:637-42.
70. Baquero F. Antibiotic resistance in Spain: What can be done? Clin Infect Dis 1996;23:819-23.
71. La moitié des prescriptions d'antibiotiques sont injustifiées. Le Monde 2001 Nov 21; p. 11.
72. Molstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance. Scand J Infect Dis 1999;31:191-5.
73. Gin AS, Carrie A, Hoban D, Weiss K, Low D, Zhanel GG. Antibiotic use is decreasing in Canada: Results of a national survey of outpatient prescription data from 1995-1999. [Abstract 135]. ICAAC. Toronto: American Society for Microbiology; 2000.
74. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002;287:3096-102.
75. Friis H, Bro F, Eriksen NR, Mabeck CE, Vejlsgaard R. The effect of reimbursement on the use of antibiotics. Scand J Prim Health Care 1993;11:247-51.
76. Korn SJ, Raufi SM, Rosenthal EJ, Shah PM. Susceptibility pattern of Streptococcus pneumoniae outpatients in Germany. Clin Microbiol Infect 2000;6:563-4.
77. Van Zuijlen DA, Schilder AG, Van Balen FA, Hoes AW. National differences in incidence of acute mastoiditis: Relationship to prescribing patterns of antibiotics for acute otitis media? Pediatr Infect Dis J 2001;20:140-4.
78. Hoppe JE, Koster S, Bootz F. Acute mastoiditis: Relevant once again. Infection 1994;22:178-82.
79. Gessner BD. Worldwide variation in incidence of Haemophilus influenzae type B meningitis and its association with ampicillin resistance. Eur J Clin Microbiol Infect Dis 2002;21:79-87.
80. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278-82.
81. Touw-Otten FW, Johansen KS. Diagnosis, antibiotic treatment and outcome of acute tonsillitis: Report of a WHO Regional Office for Europe study in 17 European countries. Fam Pract 1992;9:255-62.